| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 0% | $1,795,763 | +$171,307 | 1,129,411 | +11% | CVI Investments, Inc. | 31 Dec 2025 |
| Lind Global Fund III LP | 9.4% | -5.5% | $1,669,500 | +$851,703 | 1,050,000 | +104% | Lind Global Fund III LP | 31 Dec 2025 |
| Ayrton Capital LLC | 10% | $903,140 | 528,245 | Ayrton Capital LLC | 30 Sep 2025 | |||
| Lincoln Alternative Strategies LLC | 5.4% | $2,021,250 | 525,000 | Lincoln Alternative Strategies LLC | 17 Sep 2025 | |||
| Iroquois Capital Management, LLC | 5% | -8.2% | $871,362 | -$26,230 | 509,658 | -2.9% | Iroquois Capital Management, LLC | 30 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $1,957,398 | 508,415 | Mitchell P. Kopin | 16 Sep 2025 |
As of 31 Dec 2025, 29 institutional investors reported holding 885,150 shares of Bionano Genomics, Inc. - Common Stock, $0.0001 par value per share (BNGO). This represents 7.9% of the company’s total 11,229,947 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 885,150 | $1,354,477 | +$972,920 | $1.53 | 29 |
| 2025 Q3 | 244,406 | $417,230 | +$180,899 | $1.71 | 29 |
| 2025 Q2 | 100,433 | $328,973 | +$12,075 | $3.28 | 25 |
| 2025 Q1 | 104,118 | $290,503 | +$210,076 | $2.79 | 27 |
| 2024 Q4 | 198,732 | $57,021 | +$54,382 | $0.29 | 5 |